OBJECTIVE: Monocyte activation plays a key role in amplifying both inflammatory and coagulopathic sequelae in patients undergoing on-pump coronary artery bypass graft (CABG) surgery. Off-pump CABG diminishes, but does not eliminate, the systemic inflammatory response and its influence on monocyte activation remains unclear. This study was performed to determine if off-pump CABG suppresses all features of monocyte activation. DESIGN: Prospective, controlled, clinical study. SETTING: University-affiliated veterans affairs hospital and laboratory. PARTICIPANTS: Twenty-two patients scheduled to undergo primary CABG surgery (11 on-pump and 11 off-pump). INTERVENTIONS: On-pump and off-pump CABG surgery was performed via median sternotomy. Anticoagulation and heparin reversal were identical. Moderate hypothermia (28 degrees-30 degrees C) was used for on-pump CABG surgery, whereas temperature was maintained above 35.5 degrees C for off-pump CABG. No antifibrinolytic agents were used. MEASUREMENTS AND MAIN RESULTS: Perioperative monocyte changes were assessed by using cellular (CD11b, monocyte-platelet conjugates) and secreted markers (plasma IL-6, IL-8, and IL-10) measured at 6 time points before, during, and after CABG surgery. Off-pump CABG surgery completely blocked the increases in monocyte CD11b expression (p < 0.001) and monocyte-platelet conjugate formation (p < 0.001) observed in the on-pump group. In contrast, plasma interleukin levels were significantly elevated in both groups, although off-pump CABG surgery resulted in lower levels (p < 0.001) and a delayed time course. CONCLUSIONS: Off-pump CABG surgery attenuates monocyte secreted cytokines and completely suppresses activation-dependent monocyte cell-surface changes (CD11b, monocyte-platelet conjugate formation). Whether these pathophysiologic differences in monocyte activation translate into a reduction in adverse events after CABG surgery warrants a larger, randomized, outcomes study.
OBJECTIVE: Monocyte activation plays a key role in amplifying both inflammatory and coagulopathic sequelae in patients undergoing on-pump coronary artery bypass graft (CABG) surgery. Off-pump CABG diminishes, but does not eliminate, the systemic inflammatory response and its influence on monocyte activation remains unclear. This study was performed to determine if off-pump CABG suppresses all features of monocyte activation. DESIGN: Prospective, controlled, clinical study. SETTING: University-affiliated veterans affairs hospital and laboratory. PARTICIPANTS: Twenty-two patients scheduled to undergo primary CABG surgery (11 on-pump and 11 off-pump). INTERVENTIONS: On-pump and off-pump CABG surgery was performed via median sternotomy. Anticoagulation and heparin reversal were identical. Moderate hypothermia (28 degrees-30 degrees C) was used for on-pump CABG surgery, whereas temperature was maintained above 35.5 degrees C for off-pump CABG. No antifibrinolytic agents were used. MEASUREMENTS AND MAIN RESULTS: Perioperative monocyte changes were assessed by using cellular (CD11b, monocyte-platelet conjugates) and secreted markers (plasma IL-6, IL-8, and IL-10) measured at 6 time points before, during, and after CABG surgery. Off-pump CABG surgery completely blocked the increases in monocyte CD11b expression (p < 0.001) and monocyte-platelet conjugate formation (p < 0.001) observed in the on-pump group. In contrast, plasma interleukin levels were significantly elevated in both groups, although off-pump CABG surgery resulted in lower levels (p < 0.001) and a delayed time course. CONCLUSIONS: Off-pump CABG surgery attenuates monocyte secreted cytokines and completely suppresses activation-dependent monocyte cell-surface changes (CD11b, monocyte-platelet conjugate formation). Whether these pathophysiologic differences in monocyte activation translate into a reduction in adverse events after CABG surgery warrants a larger, randomized, outcomes study.
Authors: Natalia Lapko; Mateusz Zawadka; Jacek Polosak; George S Worthen; Gwenn Danet-Desnoyers; Monika Puzianowska-Kuźnicka; Krzysztof Laudanski Journal: Front Immunol Date: 2017-05-01 Impact factor: 7.561
Authors: Krzysztof Laudanski; Mateusz Zawadka; Jacek Polosak; Jaymin Modi; Matthew DiMeglio; Jacob Gutsche; Wilson Y Szeto; Monika Puzianowska-Kuznicka Journal: J Transl Med Date: 2018-05-25 Impact factor: 5.531
Authors: Gerwin E Engels; Y John Gu; Willem van Oeveren; Gerhard Rakhorst; Massimo A Mariani; Michiel E Erasmus Journal: J Cardiothorac Surg Date: 2013-01-09 Impact factor: 1.637
Authors: Katja R Turner; Edward C Fisher; Erinn M Hade; Timothy T Houle; Michael V Rocco Journal: Front Pharmacol Date: 2014-06-02 Impact factor: 5.810
Authors: Mario Gaudino; Gianni D Angelini; Charalambos Antoniades; Faisal Bakaeen; Umberto Benedetto; Antonio M Calafiore; Antonino Di Franco; Michele Di Mauro; Stephen E Fremes; Leonard N Girardi; David Glineur; Juan Grau; Guo-Wei He; Carlo Patrono; John D Puskas; Marc Ruel; Thomas A Schwann; Derrick Y Tam; James Tatoulis; Robert Tranbaugh; Michael Vallely; Marco A Zenati; Michael Mack; David P Taggart Journal: J Am Heart Assoc Date: 2018-08-21 Impact factor: 5.501
Authors: Tomasz Urbanowicz; Michał Michalak; Ahmed Al-Imam; Anna Olasińska-Wiśniewska; Michał Rodzki; Anna Witkowska; Assad Haneya; Piotr Buczkowski; Bartłomiej Perek; Marek Jemielity Journal: Diagnostics (Basel) Date: 2022-03-04